Active Nature Based Ingredients for Drug Discovery with Pivotal Role of Clinical Efficacy: Review and Prospective
DOI:
https://doi.org/10.12970/2308-8044.2020.08.02Keywords:
Herbs, Tropical plant diversity, Herbal therapy, Randomized controlled trials, Antioxidants, Reactive oxygen species, Polyphenols, Herbal Traditional Chinese Medicine, Traditional herbal medicine.Abstract
There is much clinical and scientific interest in finding among natural products additional active ingredients as sources that could help develop new nature-based drugs and assist conventional and herbal drugs currently available for treating human diseases. Previous and current nature based drugs were derived preferentially from plants including fungi, in addition to bacteria, and rarely also products obtained from animals or maritime sources like algae. Future approaches will likely focus on new drugs using mostly phytochemicals contained in plants known for their potential of therapeutic efficacy, studied as traditional herbal medicines including the traditional Chinese Medicine (TCM). As a cautionary, new herbal drugs will only be accepted by consumers and regulatory agencies if efficacy for certain well defined diseases has been established using randomized controlled trials (RCTs) and if severe adverse effects had not been observed, providing thereby a favorable profile of benefits over risks. Additional clinical research should consider tropical plants with their amazing diversity and availability in high numbers of different plants in tropical forests although concerns currently emerge that plant numbers may be reduced and diversity be impaired due to political, economic, and ecologic tropical forest mismanagement. Much attention also focused more recently on the Sustainable Development Goal 3 (SDG3) that supplements the 2030 UN Agenda by inspiring ideologies and implementation concerning global health and wellbeing. In conclusion and considering these goals, new drugs derived from natural products could help improve health conditions and maintain wellbeing.References
Huntingford C, Atkin OK, Martinez-de la Torre A, et al. Implications of improved representations of plant respiration in a changing climate. Nature Commun 2017; 8: Article number: 1602. https://doi.org/10.1038/s41467-017-01774-z
Stein O, Granot D. An overview of sucrose synthases in plants. Front Plant Sci 2019. https://doi.org/10.3389/fpls.2019.00095
Shanmugavelan P, Kim SY, Kim JB, et al. Evaluation of sugar content and composition in commonly consumed Korean vegetables, fruits, cereals, seed plants, and leaves by HPLC-ELSD. Carbohydr Res 2013; 380: 112-17. https://doi.org/10.1016/j.carres.2013.06.024
Xuan TD, Tawata S, Khanh TD, Chung IM. Decomposition of allelopathic plants in soil. J Agron Crop Sci 2005; 191: 162- 71. https://doi.org/10.1111/j.1439-037X.2005.00170.x
Xuan TD, Tawata S, Khanh TD, Chung IM. Biological control of weeds and plant pathogens in paddy rice by exploiting plant allelopathy: an overview. Crop Prot 2005; 24: 197-206. https://doi.org/10.1016/j.cropro.2004.08.004
Khanh TD, Cong LC, Xuan TD, Lee SJ, Kong DS, Chung IM. Weed suppressing potential of dodder (Cuscuta hygrophilae) and its phytotoxic constituents. Weed Sci 2008; 56: 119-27. https://doi.org/10.1614/WS-07-102.1
Andriana Y, Xuan TD, Quan NV, Quy TN. Allelopathic potential of Tridax procumbens L. on radish and identification of allelochemicals. Allelopath J 2018; 43: 223-38. https://doi.org/10.26651/allelo.j./2018-43-2-1143
Xuan TD, Tsuzuki E, Uematsu H, Terao H. Weed control with alfalfa pellets in transplanting rice. Weed Bio Manag 2001; 1: 231-35. https://doi.org/10.1046/j.1445-6664.2001.00034.x
Van TM, Xuan TD, Minh TN, Quan NV. Isolation and purification of potent growth inhibitors from Piper methysticum root. Molecules 2018; 23: 1907. https://doi.org/10.3390/molecules23081907
Quan NV, Xuan TD, Tran HD, Thuy NTD. Inhibitory activities of momilactones A, B, E, and 7-ketostigmasterol Isolated from rice husk on paddy and invasive weeds. Plants 2019; 8: 159. https://doi.org/10.3390/plants8060159
Minh TN, Xuan TD, Ateeque A, Elzaawely AA, Teschke R, Van TM. Efficacy from different extractions for chemical profile and biological activities of rice husk. Sustainability 2018; 10: 1356. https://doi.org/10.3390/su10051356
Quy TN, Xuan TD, Andriana Y, Tran HD, Khanh TD, Teschke R. Cordycepin isolated from Cordyceps militaris: Its newly discovered herbicidal property and potential plant-based novel alternative to Glyphosate. Molecules 2019; 24: 2901. https://doi.org/10.3390/molecules24162901
Melchart D, Hager S, Albrecht S, Dai J, Weidenhammer W, Teschke R. Herbal Traditional Chinese Medicine and suspected liver injury: A prospective study. World J Hepatol 2017; 18(9): 1141-57. https://doi.org/10.4254/wjh.v9.i29.1141
Teschke R, Zhang L. Chinese herbs and their molecules: Clinical and pathophysiological implications for the liver. J Mol Pathophysiol 2015; 4: 85-92. https://doi.org/10.5455/jmp.20150710032817
Wang R, Han D, Sun M, et al. Efficacy and safety of integration of traditional and Western medicine for the treatment of spontaneous bacterial peritonitis in liver cirrhosis: a systematic review. AME Med J 2017; 2: 138. https://doi.org/10.21037/amj.2017.08.10
Wang R, Qi X, Yoshida EM, Méndez-Sánchez N, Teschke R, Sun M, et al. Clinical characteristics and outcomes of traditional Chinese medicine-induced liver injury: a systematic review. Exp Rev Gastroenterol Hepatol 2018; 12: 425-34. https://doi.org/10.1080/17474124.2018.1427581
Teschke R, Wolff A, Frenzel C, Eickhoff A, Schulze J. Herbal traditional Chinese medicine and its evidence base in gastrointestinal disorders. World J Gastroenterol 2015; 21: 4466-90. https://doi.org/10.3748/wjg.v21.i15.4466
Teschke R, Eickhoff A, Schulze J, Wolff A, Frenzel C, Melchart D. Petadolex®, a herbal extract for migraine prophylaxis with spontaneous case reports of disputed liver injury: Robust causality evaluation by RUCAM, the Roussel Uclaf Causality Assessment Method. Eur J Pharmaceut Med Res 2016; 3: 154-77.
Teschke R, Eickhoff A. Herbal hepatotoxicity in traditional and modern medicine: Actual key issues and new encouraging steps. Front Pharmacol 2015; 6: 72. https://doi.org/10.3389/fphar.2015.00072
Frenzel C, Teschke R. Herbal hepatotoxicity: Clinical characteristics and listing compilation. Int J Mol Sci 2016; 17: 588. https://doi.org/10.3390/ijms17050588
Teschke R, Zhang L, Long H, Schwarzenboeck A, SchmidtTaenzer W, Genthner A, et al. Traditional Chinese Medicine and herbal hepatotoxicity: A tabular compilation of reported cases. Ann Hepatol 2015; 14: 7-19. https://doi.org/10.1016/S1665-2681(19)30796-3
Savelyeva T, Lee SW, Banack H. SDG3 - Good Health and Wellbeing: Re-Calibrating the SDG Agenda. In Series: Concise Guides to the United Nations Sustainable Development Goals. Emerald Group Publishing Limited, Bingley, West Yorkshire, UK; 2019. ISBN: 9781789737127. https://doi.org/10.1108/9781789737097
Kohli S. Integrated approach to nature as source of new drug lead. In: Molecular Insight of Drug Design, edited by Arli Aditya Parikesit. IntechOpen 2018. https://doi.org/10.5772/intechopen.74961
Ertl P, Schuffenhauer A. Cheminformatics analysis of natural products: Lessons from nature inspiring the design of new drugs. In: Petersen F., Amstutz R. (eds) Natural Compounds as Drugs. Progress in Drug Research, Birkhäuser Basel. 2008; Vol 66.
Newman DJ, Cragg GM. Natural products as sources of new drugs from 1981 to 2014. J Nat Prod 2016; 79: 629-61. https://doi.org/10.1021/acs.jnatprod.5b01055
Tu Y. Artemisinin - A gift from traditional Chinese medicine to the world (Nobel Lecture). Angew Chem Int Ed Engl 2016; 55: 10210-26. https://doi.org/10.1002/anie.201601967
Alamgir ANM. Drugs: their natural, synthetic, and biosynthetic sources. In: Progress in Drug Research, Springer, Cham 2017; Vol 73. https://doi.org/10.1007/978-3-319-63862-1_4
Balandrin MF, Klocke JA, Wurtele ES, Bollinger WH. Natural plant chemicals: Sources of industrial and medicinal materials. Science 1985; 228: 1154-60. https://doi.org/10.1126/science.3890182
Calixto JB. The role of natural products in modern drug discovery. Ann Acad Bras Ciênc 2019; 91(Suppl.3): e20190105. https://doi.org/10.1590/0001-3765201920190105
De Abreu IN, mailto:inabreu@yahoo.com.br Sawaya ACHF, Eberlin MN, Mazzafera P. Production of pilocarpine in callus of jaborandi (pilocarpus microphyllus stapf). In vitro Cellular & Developmental Biology - Plant 2005; 41(6): 806-11. https://doi.org/10.1079/IVP2005711
Farnsworth NR, Akerele O, Bingel AS, Soejarto DD, Guo Z. Medicinal plants in therapy. Bull World Health Organ 1985; 63: 965-81.
Koparde AA, Doijad RC, Magdum CS. Natural Products in Drug Discovery, Pharmacognosy - Medicinal Plants, Shagufta Perveen and Areej Al-Taweel, IntechOpen. 2019. DOI: 10.5772/intechopen.82860. Available at: https://www.intechopen.com/books/pharmacognosymedicinal-plants/natural-products-in-drugdiscoveryhttps://www.intechopen.com/books/pharmacognosy -medicinal-plants/natural-products-in-drug-discovery. Last accessed 24 March 2020.
Lete I, Allué J. The effectiveness of Ginger in the prevention of nausea and vomiting during pregnancy and chemotherapy. Integr Med Insights 2016; 11: 11-17. https://doi.org/10.4137/IMI.S36273
Lobay D. Rauwolfia in the treatment of hypertension. Integr Med (Encinitas) 2015; 14: 40-6.
Sarris J, Panossian A, Schweitzer I, Stough C, Scholey A. Herbal medicine for depression, anxiety and insomnia: A review of psychopharmacology and clinical evidence. Eur Neuropsychopharmacol 2011; 12: 841-60. https://doi.org/10.1016/j.euroneuro.2011.04.002
Sarris J, Stough C, Bousman CA, Wahid T, Murray G, Teschke R, et al. Kava in the treatment of generalized anxiety disorder: A double-blind, randomized, placebocontrolled study. J Clin Psychiatry 2013; 33: 643-8. https://doi.org/10.1097/JCP.0b013e318291be67
Siddiqui AA, Iram F, Siddiqui S, Sahu K. Role of natural products in drug discovery process. Int J Drug Dev Res 2014; 6: 172-204.
Teschke R, Lebot V. Proposal for a Kava Quality Standardization Code. Food Chem Toxicol 2011; 49: 2503- 16. https://doi.org/10.1016/j.fct.2011.06.075
Teschke R, Qiu SX, Xuan TD, Lebot V. Kava and kava hepatotoxicity: requirements for novel experimental, ethnobotanical, and clinical studies based on a review of the evidence. Phytother Res 2011; 25: 1262-74. https://doi.org/10.1002/ptr.3464
Teschke R, Xuan TD. Suspected herb induced liver injury by green tea extracts: Critical review and case analysis applying RUCAM for causality assessment. Jap J Gastroenterol Hepatol 2019; 1: 1-16.
Thomford NE, Senthebane DA, Rowe A, Munro D, Seele P, Maroyi A, et al. Natural products for drug discovery in the 21st century: innovations for novel drug discovery. Int J Mol Sci 2018; 19: 1578. https://doi.org/10.3390/ijms19061578
Wall ME, Wani MC. Camptothecin and taxol: discovery to clinic - thirteenth Bruce F. Cain Memorial Award Lecture. Cancer Res 1995; 55: 753-60.
Yuan H, Ma Q, Ye L, Piao G. The traditional medicine and modern medicine from natural products. Molecules 2016; 21: 559. https://doi.org/10.3390/molecules21050559
Das AK, Roy DK, Pal BC, Mahato SB. Identification of an active principle of antitumor antibiotic jawaharene with a mixture of long chain fatty acids. J Antibiotics 1982; 351: 92- 3. https://doi.org/10.7164/antibiotics.35.92
Endo Y, Oka T, Yokota S, Tsurugi K, Natori Y. The biosynthesis of a cytotoxic protein, alpha-sarcin, in a mold of Aspergillus giganteus. II. Maturation of precursor form of alpha-sarcin in vivo. Tokushima J Exp Med 1993; 40: 7-12.
Endo A. Discovery and development of the statin. In: The HMG CoA reductase inhibitors in perspective, Gaw A, Packard C.J, Shepherd J.,ed. CRC Press 1999; pp. 35-47.
Endo A. A historical perspective on the discovery of statins. Proc Jpn Acad Ser B Phys Biol Sci 2010; 86: 484-93. https://doi.org/10.2183/pjab.86.484
Langdon S, Pearce CJ. The microbial Pharmacy: FDA approved medicines from fungi. Available at: https://www. google.com/search?client=firefox-b-d&q=langdon+ Perace+2017+fda+. Last accessed 24 March 2020.
Woappi Y, Gabani P, Singh A, Singh OV. Antibiotrophs: The complexity of antibiotic-subsisting and antibiotic-resistant microorganisms. Crit Rev Microbiol 2016; 42: 17-30. https://doi.org/10.3109/1040841X.2013.875982
Chevrette MG, Carlson CM, Ortega HE, Thomas C, Ananiev GE, Barns KJ, et al. The antimicrobial potential of Streptomyces from insect microbiomes. Nature Commun 2019; 10: Article number: 516. https://doi.org/10.1038/s41467-019-08438-0
Hancock RE, Chapple DS. Peptide antibiotics. Antimicrob Agents Chemother 1999; 43: 1317-23. https://doi.org/10.1128/AAC.43.6.1317
Henry R. Etymologia: Rifampin. Emerg Infect Dis 2018; 24: 523. https://doi.org/10.3201/eid2403.ET2403
Liu Y, Yang F, Zou S, Qu L. Rapamycin: A bacteria-derived immunosuppressant that has anti-atherosclerotic effects and its clinical application. Front Pharmacol 2019; 9: 1520. https://doi.org/10.3389/fphar.2018.01520
Amin MR, Mamun SMH, Rashid R, Rahman M, Ghose A, Sharmin S, et al. Anti-snake venom: use and adverse reaction in a snake bite study clinic in Bangladesh. J Venom Anim Toxins incl Trop Dis 2008; 14: 660-72. https://doi.org/10.1590/S1678-91992008000400009
Bozoghlanian V, Butteri M. The diverse and promising world of animal derived medications. Pharos Alpha Omega Alpha Honor Med Soc Winter 2015; 78: 16-22.
Costa-Neto EM. Animal-based medicine: biological prospection and the sustainable use of zootherapeutic resources. Ann Brazil Acad Sci 2005; 77: 33-43. https://doi.org/10.1590/S0001-37652005000100004
Ferraz CR, Arrahman A, Xie C, Casewell NR, Richard J. Lewis RJ, et al. Multifunctional Toxins in snake venoms and therapeutic implications: From pain to hemorrhage and necrosis Front Ecol. Evol 2019. https://doi.org/10.3389/fevo.2019.00218
WHO. WHO guidelines for the production, control and regulation of snake antivenom immunoglobulins. 2018. Available at: https://www.who.int/bloodproducts/snake_ antivenoms/snakeantivenomguide/en/ Last accessed 24 March 2020.
Alves C, Silva J, Pinteus S, Gaspar H, Alpoim MC, Botana LM, et al. From marine origin to therapeutics: The antitumor potential of marine algae-derived compounds. Front Pharmacol 2018; 9: 777. https://doi.org/10.3389/fphar.2018.00777
Jimenez PC, Wilke DV, Costa-Lotufo LV. Marine drugs for cancer: surfacing biotechnical innovations from the oceans. Clinics 2018; 73: e482s. https://doi.org/10.6061/clinics/2018/e482s
Pooja S. Algae used as medicine and food - a short review. J Pharm Sci Res 2014; 6: 33-5.
Wang S, Alseekh S, Fernie AR, Luo J. The structure and function of major plant metabolite modifications. Mol Plant 2019; 12: 899-919. https://doi.org/10.1016/j.molp.2019.06.001
Teschke R, Xuan TD. Herbs including shell ginger, antioxidant profiles, aging, and longevity in Okinawa, Japan: A critical analysis of current concepts. In: Aging: Oxidative Stress and Dietary Antioxidants, Victor R. Preedy and Vinood B. Patel, Eds. Second edition. Academic Press, imprint of Elsevier 2020 in press.
Teschke R, Xuan TD. Viewpoint: A contributory role of Shell ginger (Alpinia zerumbet) for human longevity of Okinawa in Japan? Nutrients 2018; 10: 166. https://doi.org/10.3390/nu10020166
Schulze J, Melzer L, Smith L, Teschke R. Green tea and its extracts in cancer prevention and treatment. Beverages 2017; 3: 17. https://doi.org/10.3390/beverages3010017
Teschke R, Schulze J. Editorial: Green tea and the question of reduced liver cancer risk: The dawn of potential clinical relevance? HepatoBiliary Surgery and Nutrition 2017; 6: 122- 6. https://doi.org/10.21037/hbsn.2017.03.03
Oz HS, Chen TS. Green-tea polyphenols downregulate cyclooxygenase and Bcl-2 activity in acetaminophen-induced hepatotoxicity. Dig Dis Sci 2008; 53: 2980-8. https://doi.org/10.1007/s10620-008-0239-5
Oz HS, Im HJ, Chen TS, de Villiers WJ, McClain CJ. Glutathione-enhancing agents protect against steatohepatitis in a dietary model. J Biochem Mol Toxicol 2006; 20: 39-47. https://doi.org/10.1002/jbt.20109
Wang W, Xiong X, Li X, Zhang Q, Yang W, Du L. In silico investigation of the anti-tumor mechanisms of epigallocatechin-3-gallate. Molecules 2019; 24: 1445. https://doi.org/10.3390/molecules24071445
Yang Y, Zhang T. Antimicrobial activities of tea polyphenol on phytopathogens: a review. Molecules 2019; 24: 816. https://doi.org/10.3390/molecules24040816
Naumovski N, Foscolou A, D'Cunha NM, Tyrovolas S, Chrysohoou C, Sidossis LS, et al. The association between green and black tea consumption on successful aging: a combined analysis of the ATTICA and MEDiterranean ISlands (MEDIS) epidemiological studies. Molecules 2019; 24: 1862. https://doi.org/10.3390/molecules24101862
Quan NV, Tran HD, Xuan TD, Ahmad A, Dat TD, Khanh TD, et al. Momilactones A and B are α-amylase and αglucosidase inhibitors. Molecules 2019; 24: 482. https://doi.org/10.3390/molecules24030482
Oz HS. Chronic inflammatory diseases and green tea polyphenols. Nutrients 2017; 9: 561. https://doi.org/10.3390/nu9060561
Boehm K, Borrelli F, Ernst E, Habacher G, Hung SK, Milazzo S, et al. Green tea (Camellia sinensis) for the prevention of cancer. Cochrane Database of Systematic Reviews 2009; Issue 3: Art. No.: CD005004. https://doi.org/10.1002/14651858.CD005004.pub2
Santesso N, Manheimer E. A summary of a cochrane review: green and black tea for the primary prevention of cardiovascular disease. Glob Adv Health 2014; 3: 66-7. https://doi.org/10.7453/gahmj.2014.003
Peng X, Zhou R, Wang B, Yu X, Yang X, Liu K, et al. Effect of green tea consumption on blood pressure: A metaanalysis of 13 randomized controlled trials. Scientific Reports 2014; 4: Article number: 6251. https://doi.org/10.1038/srep06251
Xuan TD, Teschke R. Dihydro-5,6-dehydrokavain (DDK) from Alpinia zerumbet: Its isolation, synthesis, and characterization. Molecules 2015; 20: 16306-19. https://doi.org/10.3390/molecules200916306
Li S, Li SK, Gan RY, Song FL, Kuang L, Li HB. Antioxidant capacities and total phenolic contents of infusions from 223 medicinal plants. Ind Crop Prod 2013; 51: 289-98. https://doi.org/10.1016/j.indcrop.2013.09.017
Deng GF, Lin X, Xu XR, Gao LL, Xie JF, Li HB. Antioxidant capacities and total phenolic contents of 56 vegetables. J Funct Food 2013; 5: 260-6. https://doi.org/10.1016/j.jff.2012.10.015
Fu L, Xu BT, Xu XR, Gan RY, Zhang Y, et al. Antioxidant capacities and total phenolic contents of 62 fruits. Food Chem 2011; 129: 345-50. https://doi.org/10.1016/j.foodchem.2011.04.079
Shan B, Cai YZ, Sun M, Corke H. Antioxidant capacity of 26 spice extracts and characterization of their phenolic constituents. J Agric Food Chem 2005; 53: 7749-59. https://doi.org/10.1021/jf051513y
Xu DP, Li Y, Meng X, Zhou T, Zhou Y, Zheng J, et al. Natural antioxidants in foods and medicinal plants: Extraction, assessment and resources. Int J Mol Sci 2017; 18: 96. https://doi.org/10.3390/ijms18010096
Niwano Y, Beppu F, Shimada T, Kyan M, Yasura K, Tamaki M, et al. Extensive screening for plant food stuff in Okinawa, Japan with anti-obese activity on adipocytes in vitro. Plant Foods Hum Nutr 2009; 64: 6-10. https://doi.org/10.1007/s11130-008-0102-z
Marseglia L, Manti S, D’Angelo G, Nicotera A, Parisi E, Di Rosa G, et al. Oxidative stress in obesity: a critical component in human diseases. Int J Mol Sci 2015; 16: 378- 400. https://doi.org/10.3390/ijms16010378
Liu Z, Ren Z, Zhang J, Chuang CC, Kandaswamy E, Zhou T, et al. Role of ROS and nutritional antioxidants in human diseases. Front Physiol 2018; 9: 477. https://doi.org/10.3389/fphys.2018.00477
Teschke R. Alcoholic liver disease: Alcohol metabolism, cascade of molecular mechanisms, cellular targets, and clinical aspects. Biomedicines 2018; 6: 106. https://doi.org/10.3390/biomedicines6040106
Teschke R. Microsomal ethanol-oxidizing system (MEOS): Success over 50 years and an encouraging future. Alcoholism, Clin Exp Res 2019; 43: 386-400. https://doi.org/10.1111/acer.13961
Teschke R. Alcoholic liver disease: Current mechanistic aspects with focus on their clinical relevance. Biomedicines 2019; 7: 68. https://doi.org/10.3390/biomedicines7030068
Teschke R, Zhu Y. Opinion: Intestinal microbiome, endotoxins, cytochrome P450 2E1, and the gut-liver axis in alcoholic liver disease EC Gastroenterology Dig Syst 2019; 5: 11.
Teschke R. Aliphatic halogenated hydrocarbons: Liver injury in 60 patients. J Clin Transl Hepatol 2018; 6: 1-12. https://doi.org/10.14218/JCTH.2018.00040
Teschke R, Zhang L, Melzer L, Schulze J, Eickhoff A. Green tea extract and the risk of drug-induced liver injury. Expert Opin Drug Metab Toxicol 2014; 10: 1663-76. https://doi.org/10.1517/17425255.2014.971011
Teschke R, Zhu Y. Paracetamol (acetaminophen), alcohol, and liver injury: Biomarkers, clinical issues, and experimental aspects. SL Pharmacol Toxicol 2018; 1: 113.
Teschke R, Larrey D, Melchart D, Danan G. Traditional Chinese Medicine (TCM) and herbal hepatotoxicity: RUCAM and the role of novel diagnostic biomarkers such as microRNAs. Medicines 2016; 3: 18. https://doi.org/10.3390/medicines3030018
Pandey KB, Rizvi, SH. Plant polyphenols as dietary antioxidants in human health and disease. Oxidat Med Cell Longevity 2009; 2: 270-8. https://doi.org/10.4161/oxim.2.5.9498
Sadowska-Bartosz I, Bartosz G. Effect of antioxidants supplementation on aging and longevity. BioMed Res Int 2014; Article ID 404680. https://doi.org/10.1155/2014/404680
Calabrese V, Cornelius C, Dinkova-Kostova AT, Iavicoli I, Di Paola R, Koverech A, et al. Cellular stress responses, hormetic phytochemicals and vitagenes in aging and longevity. Biochim Biophys Acta 2012; 1822: 753-83. https://doi.org/10.1016/j.bbadis.2011.11.002
Conti V, Izzo V, Corbi G, Russomanno G, Manzo V, De Lise F, et al. Antioxidant supplementation in the treatment of aging-associated diseases. Front Pharmacol 2016; 7: 24. https://doi.org/10.3389/fphar.2016.00024
Bianchi E, Falcioni C. Reactive oxygen species, health and longevity. AIMS Mol Sci 2016; 3: 479-504. https://doi.org/10.3934/molsci.2016.4.479
Liou G Y, Storz P. Reactive oxygen species in cancer. Free Rad Res 2010; 44: 479-96. https://doi.org/10.3109/10715761003667554
Prasad S, Gupta SC, Tyagi AK, Reactive oxygen species (ROS) and cancer: Role of antioxidative nutraceuticals. Cancer Lett 2017; 387: 95-105. https://doi.org/10.1016/j.canlet.2016.03.042
Mitra S, Nguyen LN, Akter M, Park G, Choi EH, Kaushik NK. Impact of ROS generated by chemical, physical, and plasma techniques on cancer attenuation. Cancers (Basel) 2019; 11: 1030. https://doi.org/10.3390/cancers11071030
Russo GL, Tedesco I, Spagnuolo C, Russo M. Antioxidant polyphenols in cancer treatment: Friend, foe or foil? Sem Cancer Biol 2017; 46: 1-13. https://doi.org/10.1016/j.semcancer.2017.05.005
Zhou Y, Zheng J, Li, Y, Xu D P, Li S, Chen Y M, et al. Natural polyphenols for prevention and treatment of cancer. Nutrients 2016; 8: 515. https://doi.org/10.3390/nu8080515
Mazzanti G, Di Soto A, Vitalone A. Hepatotoxicity of green tea: An update. Arch Toxicology 2015; 89: 1175-91. https://doi.org/10.1007/s00204-015-1521-x
Teschke R, Eickhoff A, Wolff A, Xuan TD. Liver injury from herbs and “dietary supplements”: Highlights of a literature review from 2015 to 2017. Curr Pharmacol Rep 2018; 4: 120- 31. https://doi.org/10.1007/s40495-018-0124-7
Bounda GA, Yu F. Review of clinical studies of Polygonum multiflorum Thund. and its isolated bioactive components. Pharmacognosy Res 2015; 7: 225-36. https://doi.org/10.4103/0974-8490.157957
Liu Y, Wang Q, Yang J, Guo X, Liu W, Ma S, et al. Polygonum multiflorum Thunb.: A review on chemical analysis, processing mechanism, quality evaluation, and hepatotoxicity. Front Pharmacol 2018; 9: 364. https://doi.org/10.3389/fphar.2018.00364
Wang J, Ma Z, Niu M, Zhu Y, Liang Q, Zhao Y, et al. Evidence chain-based causality identification in herb-induced liver injury: exemplification of a well-known liver-restorative herb Polygonum multiflorum. Front Med 2015; 9: 457-67. https://doi.org/10.1007/s11684-015-0417-8
Schmidt M, Morgan M, Bone K, McMillan J. Kava: a riskbenefit assessment. In: Mills M, Bone K (Eds). The essential guide to herbal safety. Elsevier Churchill Livingstone, St. Louis (Missouri), 2005; pp. 155-221.
Teschke R, Schwarzenboeck A, Hennermann KH. Kava hepatotoxicity: a clinical survey and critical analysis of 26 suspected cases. Eur J Gastroenterol Hepatol 2008; 20: 1182-93. https://doi.org/10.1097/MEG.0b013e3283036768
Teschke R, Schwarzenboeck A, Akinci A. Kava hepatotoxicity: a European view. New Zeal Med J 2008; 121: 1283.
Teschke R. Kava hepatotoxicity: a clinical review. Ann Hepatol 2010; 9: 251-265. https://doi.org/10.1016/S1665-2681(19)31634-5
Teschke R. Kava hepatotoxicity: pathogenetic aspects and prospective considerations. Liver Int 2010; 30: 1270-79. https://doi.org/10.1111/j.1478-3231.2010.02308.x
Teschke R, Schulze J. Risk of kava hepatotoxicity and the FDA consumer advisory. J Am Med Ass 2010; 304: 2174-75. https://doi.org/10.1001/jama.2010.1689
Schmidt M. German court ruling reverses kava ban: German regulatory authority appeals decision. Herbal Gram 2014; 103: 38-43.
Kuchta K, Schmidt M, Nahrstedt A. German kava ban lifted by court: The alleged hepatotoxicity of kava (Piper methysticum) as a case of ill-defined herbal drug identity, lacking quality control, and misguided regulatory politics. Planta Med 2015; 81: 1647-53. https://doi.org/10.1055/s-0035-1558295
Kuchta K, de Nicola P, Schmidt M. Randomized, dosecontrolled double-blind trial: Efficacy of an ethanolic kava (Piper methysticum rhizome) extract for the treatment of anxiety in elderly patients. Trad Kampo Med 2018; 5: 3-10. https://doi.org/10.1002/tkm2.1079
Califf RM, Zarin DA, Kramer JM, Sherman RE, Aberle LH, Tasneem A. Characteristics of clinical trials registered in ClinicalTrials.gov, 2007-2010. JAMA 2012; 307: 838-47. https://doi.org/10.1001/jama.2012.3424
Chen J, Huang J, Li JV, Lv Y, He Y, Zheng Q, et al. The characteristics of TCM clinical trials: A systematic review of Clinical Trials.gov. Evid Based Complement Alternat Med 2017: 9461415. https://doi.org/10.1155/2017/9461415
Yang F, Wang H, Zou J, Li X, Jin X, Cao Y, et al. Assessing the methodological and reporting quality of network metaanalyses in Chinese medicine. Medicine (Baltimore) 2018; 97: e13052. https://doi.org/10.1097/MD.0000000000013052
Zhang X, Tian R, Yang Z, Zhao C, Yao L, Lau C, et al. Quality assessment of clinical trial registration with traditional Chinese medicine in WHO registries. BMJ Open 2019; 9: e025218. https://doi.org/10.1136/bmjopen-2018-025218
Teschke R, Danan G. Causality assessment in pharmacovigilance for herbal medicines. In: Pharmacovigilance of herbal medicines: Reflections, solutions and future perspectives. Editor: Joanne Barnes, Springer (Adis Books): 2020; in press.
Danan G, Teschke R. RUCAM in drug and herb induced liver injury: the update. In: Special issue: Drug, herb, and dietary supplement hepatotoxicity, guest editors Rolf Teschke and Raúl Andrade. Int J Mol Sci 2016; 17: 14. https://doi.org/10.3390/ijms17010014
Teschke R. Idiosyncratic DILI: Analysis of 46,266 cases assessed for causality by RUCAM and published from 2014 to early 2019. In: Special issue: Clinical drug induced liver injury: Current diagnostic and mechanistic challenges, guest editors: Rolf Teschke, Gaby Danan, James H. Lewis. Front Pharmacol 2019; 10: 730. https://doi.org/10.3389/fphar.2019.00730
Danan G, Teschke R. Roussel Uclaf Causality Assessment Method for drug-induced liver injury. In: Special issue: Clinical drug induced liver injury: Current diagnostic and mechanistic challenges, guest editors: Rolf Teschke, Gaby Danan, James H. Lewis. Front Pharmacol 2019; 10: 853. https://doi.org/10.3389/fphar.2019.00853
Danan G, Teschke R. Drug-induced liver injury: Why is the Roussel Uclaf Causality Assessment Method (RUCAM) still used 25 years after its launch? Drug Saf 2018, 41: 735-43. https://doi.org/10.1007/s40264-018-0654-2
Zhu Y, Niu M, Chen J, Zou ZS, Ma ZJ, Liu SH, et al. Comparison between Chinese herbal medicine and Western medicine-induced liver injury of 1985 patients. J Gastroenterol Hepatol 2016; 31: 1476-82. https://doi.org/10.1111/jgh.13323
Jing J, Teschke R. Traditional Chinese medicine (TCM) and herb induced liver injury: comparison with drug induced liver injury. J Clin Transl Hepatol 2018; 6: 57-68. https://doi.org/10.14218/JCTH.2017.00033
Jing J, Wang RL, Zhao XY, Zhu Y, Niu M, Wang LF, et al. Association between the concurrence of pre-existing chronic liver disease and worse prognosis in patients with an herb - Polygonum multiflorum thunb. induced liver injury: a casecontrol study from a specialised liver disease center in China. BMJ Open 2019; 9: e023567. https://doi.org/10.1136/bmjopen-2018-023567
Zhu Y, Niu M, Wang JB, Wang RL, Li JY, Ma YQ, et al. Predictors of poor outcomes in 488 patients with herbinduced liver injury. Turk J Gastroenterol 2019; 30: 47-58. https://doi.org/10.5152/tjg.2018.17847
Teschke R, Zhu Y, Jing J. Herb induced liver injury in Asia and current role of RUCAM for causality assessment in 11,160 published cases. J Clin Transl Hepatol 2020, in press.
